Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.70 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.70 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.43 |
| ▸ | ENPEP | Q07075 | 5/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.38 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.37 |
| ▸ | GSR | P00390 | 2/20 | 0.37 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.37 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.37 |
| ▸ | GRM1 | Q13255 | 2/20 | 0.37 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.37 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.37 |
| ▸ | GRM8 | O00222 | 1/20 | 0.37 |
| ▸ | GRM6 | O15303 | 1/20 | 0.37 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.37 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | GRM5 | P41594 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cysteine SCHEMBL3396295 | 1.00 | PTGS1 (0.70) | PTGS1SLC7A11LMNASLC1A1ENPEP | |
| Cysteine SCHEMBL888042 | 0.93 | PTGS1 (0.73) | PTGS1SLC7A11LMNASLC1A1ENPEP | |
| Cysteine SCHEMBL888041 | 0.93 | PTGS1 (0.73) | PTGS1SLC7A11LMNASLC1A1ENPEP | |
| Dl-Dithiothreitol SCHEMBL23883128 | 0.89 | PTGS1 (0.55) | PTGS1SLC7A11LMNASLC1A1ENPEP | |
| Dl-Dithiothreitol SCHEMBL23883129 | 0.89 | PTGS1 (0.55) | PTGS1SLC7A11LMNASLC1A1ENPEP | |
| Cystine SCHEMBL9615032 | 0.84 | PTGS1 (0.48) | PTGS1SLC7A11LMNASLC1A1ENPEP | |
| Cystine SCHEMBL9615040 | 0.84 | PTGS1 (0.48) | PTGS1SLC7A11LMNASLC1A1ENPEP | |
| Serine SCHEMBL17113864 | 0.84 | PTGS1 (0.80) | PTGS1SLC7A11SLC1A1ENPEPGSR | |
| Serine SCHEMBL1162414 | 0.84 | PTGS1 (0.80) | PTGS1SLC7A11SLC1A1ENPEPGSR | |
| Serine SCHEMBL1162408 | 0.84 | PTGS1 (0.80) | PTGS1SLC7A11SLC1A1ENPEPGSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3902525-A1 | OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING OCULAR SURFACE DISEASE | Surface Ophthalmics, Inc. (US) | 2021-11-03 | — | — | EP | claimed |
| WO-2020139525-A1 | OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING OCULAR SURFACE DISEASE | SURFACE PHARMACEUTICALS, INC. (US) | 2020-07-02 | — | — | WO | claimed |
| WO-2014127015-A1 | EPINEPHRINE FORMULATIONS FOR MEDICINAL PRODUCTS | YS PHARM TECH (US) | 2014-08-21 | — | — | WO | claimed |
| WO-2014127020-A1 | EPINEPHRINE FORMULATIONS FOR MEDICINAL PRODUCTS | YS PHARMTECH (US) | 2014-08-21 | — | — | WO | claimed |
| WO-2014127018-A1 | EPINEPHRINE FORMULATIONS FOR MEDICINAL PRODUCTS | YS PHARMTECH (US) | 2014-08-21 | — | — | WO | claimed |
| EP-0518905-B1 | SILVER REMOVAL FROM PHOTOGRAPHIC PRODUCTS | KODAK LTD (GB) | 1994-06-29 | — | — | EP | claimed |
| EP-0518905-A1 | SILVER REMOVAL FROM PHOTOGRAPHIC PRODUCTS. | KODAK LTD (GB) | 1992-12-23 | — | — | EP | claimed |
| WO-1991014205-A1 | SILVER REMOVAL FROM PHOTOGRAPHIC PRODUCTS | EASTMAN KODAK COMPANY (US) | 1991-09-19 | — | — | WO | claimed |
| US-20230201632-A1 | METHODS FOR FIXING HAIR AND SKIN | GOLDMAN SACHS BANK USA | 2023-06-29 | — | — | US | disclosed |
| US-20230104929-A1 | METHODS FOR FIXING HAIR AND SKIN | GOLDMAN SACHS BANK USA | 2023-04-06 | — | — | US | disclosed |
| EP-4008306-A1 | METHODS FOR FIXING HAIR AND SKIN | Olaplex, Inc. (US) | 2022-06-08 | — | — | EP | disclosed |
| US-11135150-B2 | Compositions and methods for improving the quality of chemically treated hair | L'OREAL (FR) | 2021-10-05 | — | — | US | disclosed |
| CN-105431128-B | Method for repairing hair and skin | 奥拉普莱克斯股份有限公司 | 2021-07-30 | — | — | CN | disclosed |
| US-20210046334-A1 | METHODS FOR FIXING HAIR AND SKIN | GOLDMAN SACHS BANK USA, AS ADMINISTRATIVE AGENT | 2021-02-18 | — | — | US | disclosed |
| EP-1650191-A1 | THERAPEUTIC AGENT FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND METHOD OF TREATMENT FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH THE SAME | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2006-04-26 | — | — | EP | disclosed |
| US-6706733-B2 | THE BETA CRYSTAL FORM AND/OR GAMMA CRYSTAL FORM | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2004-03-16 | — | — | US | disclosed |
| US-20030087929-A1 | Quinolinone derivative formulation and its production method | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-05-08 | — | — | US | disclosed |
| CN-1396828-A | Pharmaceutical composition comprising Pemetrexed together with monothioglycerol L-cystein or thioglycolic acid | LILLY CO ELI (US) | 2003-02-12 | — | — | CN | disclosed |
| EP-0298684-B1 | CROSSLINKING REAGENTS USEFUL IN TREATING HAIR | UNILEVER PLC (GB) | 1993-04-21 | — | — | EP | disclosed |
| EP-0298684-A2 | Crosslinking reagents useful in treating hair | UNILEVER PLC (GB) | 1989-01-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210046334-A1 | METHODS FOR FIXING HAIR AND SKIN | CUTA, SUCLG1, TST | PTGS1 819/4885SLC7A11 860/4885LMNA 1250/4885 |
| US-11135150-B2 | Compositions and methods for improving the quality of chemically treated hair | SRM, TET2, TET3 | PTGS1 3609/4885SLC7A11 2196/4885LMNA 1181/4885 |
| US-20230201632-A1 | METHODS FOR FIXING HAIR AND SKIN | CUTA, SUCLG1, TST | PTGS1 819/4885SLC7A11 860/4885LMNA 1250/4885 |
| US-20030087929-A1 | Quinolinone derivative formulation and its production method | CYP3A5, CYP2F1, CYP3A7 | PTGS1 450/4885SLC7A11 389/4885LMNA 4186/4885 |
| US-20230104929-A1 | METHODS FOR FIXING HAIR AND SKIN | CUTA, SUCLG1, TST | PTGS1 819/4885SLC7A11 860/4885LMNA 1250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.